These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 8920074

  • 1. [Low prevalence of ant-hepatitis c virus antibodies in hepatocellular carcinoma in Senegal].
    Ka MM, Herve P, Leguenno B, Ndiaye MF, Diop TM, Diop B, Dangou JM, Bao O, Brechot C.
    Ann Gastroenterol Hepatol (Paris); 1996; 31(6):329-32. PubMed ID: 8920074
    [Abstract] [Full Text] [Related]

  • 2. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 3. [Serum anti-hepatitis C virus and hepatitis C virus RNA in patients with hepatocellular carcinoma].
    Jiang MD.
    Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):131-4, 189. PubMed ID: 7686810
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
    Edamoto Y, Tani M, Kurata T, Abe K.
    Cancer; 1996 May 01; 77(9):1787-91. PubMed ID: 8646675
    [Abstract] [Full Text] [Related]

  • 5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S, Nakashima Y, Kojiro M, Tabor E.
    J Viral Hepat; 2005 May 01; 12(3):325-9. PubMed ID: 15850475
    [Abstract] [Full Text] [Related]

  • 6. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
    Yano Y, Yamashita F, Sumie S, Ando E, Fukumori K, Kiyama M, Oyama T, Kuroki S, Kato O, Yamamoto H, Tanaka M, Sata M.
    Am J Gastroenterol; 2002 Jan 01; 97(1):156-61. PubMed ID: 11808941
    [Abstract] [Full Text] [Related]

  • 7. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
    Resnick RH, Koff R.
    Arch Intern Med; 1993 Jul 26; 153(14):1672-7. PubMed ID: 7687423
    [Abstract] [Full Text] [Related]

  • 8. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, Huang GT, Yang PM, Lee H, Chen CJ.
    Cancer Epidemiol Biomarkers Prev; 1996 Mar 26; 5(3):173-8. PubMed ID: 8833617
    [Abstract] [Full Text] [Related]

  • 9. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
    Shim J, Kim BH, Kim NH, Dong SH, Kim HJ, Chang YW, Lee JI, Chang R.
    J Gastroenterol Hepatol; 2005 May 26; 20(5):746-51. PubMed ID: 15853989
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
    Suga M, Senota A, Arima K, Kodama T, Ikuta S, Sakamoto H, Ohe Y, Sugai S, Yachi A.
    Hepatogastroenterology; 1994 Oct 26; 41(5):438-41. PubMed ID: 7531667
    [Abstract] [Full Text] [Related]

  • 11. High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma.
    Nakagawa N, Ikoma J, Ishihara T, Yasui N, Fujita N, Iwasa M, Kaito M, Watanabe S, Adachi Y.
    Cancer; 1999 Oct 15; 86(8):1437-40. PubMed ID: 10526270
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population.
    Tanaka K, Hirohata T, Koga S, Sugimachi K, Kanematsu T, Ohryohji F, Nawata H, Ishibashi H, Maeda Y, Kiyokawa H.
    Cancer Res; 1991 Jun 01; 51(11):2842-7. PubMed ID: 1851661
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to hepatitis C virus among patients with hepatocellular carcinoma and blood donors in Thailand.
    Petchclai B, Srivatanakul P, Puntanee K, Hiranras S, Chiewsilp P, Kunakorn M, Liemsuwan C.
    J Med Assoc Thai; 1992 Jan 01; 75 Suppl 1():168-71. PubMed ID: 1383370
    [Abstract] [Full Text] [Related]

  • 14. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M.
    Alcohol Clin Exp Res; 2003 Aug 01; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [Abstract] [Full Text] [Related]

  • 15. Previous or occult hepatitis B virus infection in hepatitis B surface antigen-negative and anti-hepatitis C-negative patients with hepatocellular carcinoma.
    Ohba K, Kubo S, Tamori A, Hirohashi K, Tanaka H, Shuto T, Nishiguchi S, Kinoshita H.
    Surg Today; 2004 Aug 01; 34(10):842-8. PubMed ID: 15449154
    [Abstract] [Full Text] [Related]

  • 16. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.
    Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327
    [Abstract] [Full Text] [Related]

  • 17. Antibody to hepatitis B core antigen is associated with the development of hepatocellular carcinoma in hepatitis C virus-infected persons: a 12-year prospective study.
    Tanaka K, Nagao Y, Ide T, Kumashiro R, Sata M.
    Int J Mol Med; 2006 May 01; 17(5):827-32. PubMed ID: 16596267
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma.
    Pramoolsinsap C, Sumalnop K, Busagorn N, Kurathong S.
    Southeast Asian J Trop Med Public Health; 1992 Mar 01; 23(1):6-11. PubMed ID: 1326124
    [Abstract] [Full Text] [Related]

  • 19. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.
    Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, Bréchot C.
    Hepatology; 1993 Jan 01; 17(1):20-9. PubMed ID: 8380790
    [Abstract] [Full Text] [Related]

  • 20. Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.
    Khan A, Kurbanov F, Tanaka Y, Elkady A, Sugiyama M, Dustov A, Mizokami M.
    J Med Virol; 2008 Feb 01; 80(2):268-76. PubMed ID: 18098133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.